Yes, current dermatological research indicates that a disrupted microbiome, a state known as dysbiosis, is a primary driver of rosacea-like flushing and persistent erythema. The skin's commensal microorganisms serve as a vital immunological shield; when this balance is compromised, the innate immune system becomes hyper-reactive. Specifically, an overgrowth of the mite Demodex folliculorum and its associated bacteria, such as Bacillus oleronius, triggers an inflammatory cascade that leads to the dilation of superficial blood vessels and the characteristic flushing response [1][2].
Furthermore, a shift in the microbial landscape weakens the skin’s physical barrier, allowing environmental triggers to penetrate more easily. This disruption activates Toll-like receptor 2 (TLR2), which stimulates the production of cathelicidin LL-37—a proinflammatory peptide found in significantly higher levels in individuals experiencing rosacea-like symptoms. This process not only induces redness but also promotes angiogenesis, the formation of new, fragile blood vessels that exacerbate chronic flushing [3][4].
The skin microbiome is a complex ecosystem consisting of bacteria, fungi, and viruses that communicate directly with our immune cells. In a healthy state, these microbes produce antimicrobial peptides and maintain an acidic pH that prevents the colonisation of pathogens. However, when the diversity of this population decreases, the skin enters a state of chronic low-grade inflammation. This neurovascular dysregulation is what connects microbial shifts to the physical sensation of heat and visible redness [2][5].
Beyond the skin's surface, scientists are increasingly investigating the 'gut-skin axis.' Evidence suggests that small intestinal bacterial overgrowth (SIBO) and other gastrointestinal imbalances can influence systemic inflammation, which manifests as cutaneous flushing. This suggests that the 'disrupted microbiome' responsible for facial redness may not be limited to the face itself, but may reflect a systemic microbial imbalance that influences the body's inflammatory threshold [1][6].
For those looking to support a compromised skin barrier, our Balance Biome Crème is formulated with Bifida Ferment Lysate to help encourage a more resilient, balanced environment. We often suggest pairing this with Surface Calm, a ceramide-based cleanser designed to provide a gentle, non-stripping cleanse that respects the skin’s delicate microbial defence system.
FAQ
How does Demodex mite overgrowth contribute to redness?
While Demodex mites are normal inhabitants of human skin, their density is often 15 to 18 times higher in patients with rosacea-like symptoms. These mites carry bacteria that, when released upon the mite's death, act as antigens. This triggers an immune response characterised by neutrophil infiltration and the release of reactive oxygen species, directly causing tissue damage and vascular dilation [2][4].
Can using too many active skincare products disrupt the microbiome?
Yes, 'over-cleansing' and the excessive use of harsh acids or high-strength retinoids can alter the skin's pH and strip essential lipids. This alkaline shift creates an environment where beneficial bacteria like Staphylococcus epidermidis struggle to survive, allowing pro-inflammatory species to dominate, leading to a compromised barrier and increased susceptibility to flushing [3][5].
Does restoring the microbiome improve facial flushing?
Clinical trials have shown that incorporating topical probiotics or prebiotics can help stabilise the skin's microbial environment. By fostering the growth of commensal bacteria, these formulations can reduce the activity of inflammatory proteases and help down-regulate the vascular responses that lead to persistent redness and stinging sensations [1][6].
References:
[1] Daou H, et al. Dermatology and Therapy. 2021;11(1):1-12. doi:10.1007/s13555-020-00460-1
[2] Woo YR, et al. International Journal of Molecular Sciences. 2020;21(22):8702. doi:10.3390/ijms21228702
[3] Gallo RL, et al. Journal of Investigative Dermatology. 2017;137(6):1213-1215. doi:10.1016/j.jid.2017.01.009
[4] Lacey N, et al. Journal of Medical Microbiology. 2007;56(4):507-512. doi:10.1099/jmm.0.47051-0
[5] Chen YE, et al. Nature Reviews Microbiology. 2018;16(3):143-155. doi:10.1038/nrmicro.2017.157
[6] Salem I, et al. Frontiers in Microbiology. 2018;9:1459. doi:10.3389/fmicb.2018.01459
